Profile: Anika Therapeutics, Inc. develops therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body. HA enhances joint function and coats, protects, cushions and lubricates soft tissues. HA also is present in the skin, where it supports skin structure and elasticity. We manufacture and distribute a diverse portfolio of HA-based products that cover a broad range of therapeutic applications. These products include Orthovisc®, Orthovisc ® mini, and Monovisc™, used in the treatment of osteoarthritis; Hyvisc® used in the treatment of equine osteoarthritis; the Elevess™ family of cosmetic dermatology products for facial wrinkles, scar remediation and lip augmentation.
FDA Registration Number: 3007093114
14 Products/Services (Click for related suppliers)
|
• Aesthetic Dermal Implant (FDA Code: LMH) |
• Anti-Adhesion Barrier Gels |
• Barrier Gels |
• Dermal Fillers |
• Injection Supplements |
• Intraarticular Hyaluronic Acid (FDA Code: MOZ) |
• Nonpyrogenic Viscoelastic Solutions, Sterile & Transparent |
• Osteoarthritis Pain Management |
• Pain Management System |
• Peridural Fibrosis (Adhesion Barrier) Inhibitor, Absorbable (FDA Code: MLQ) |
• Sterile Transparent Viscoelastic Gels |
• Viscoelastic Gels |
• Viscoelastic Solution |
• Viscoelastic Surgical Aid (FDA Code: LZP / 886.4275) An intraocular fluid is a device consisting of a nongaseous fluid intended to be introduced into the eye to aid performance of surgery, such as to maintain anterior chamber depth, preserve tissue integrity, protect tissue from surgical trauma, or function as a tamponade during retinal reattachment. |